Purdue Pharma Is Providing 340B Refunds Spanning 16 Years of Overcharges

Purdue Pharma announced refunds for 340B overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—more than half of the 340B program's existence.

Purdue Pharma’s Avrio Health subsidiary is giving 340B covered entities refunds for overcharges on Betasept antiseptic surgical scrub for purchases spanning 16 years—from Q2 2005 through Q2 2021.

Please Login or Become a Paid Subscriber to

Read More »

HRSA Unveils New 340B Contract Pharmacy Services Webpage That Is Silent on Manufacturer Obligations

HRSA has posted a new 340B Contract Pharmacy Services webpage that addresses requirements for covered entities but not for pharmaceutical manufacturers.

The U.S. Health Resources and Services Administration overnight posted a new Contract Pharmacy Services page on the 340B program website that addresses requirements for covered entities but not for pharmaceutical manufacturers.

Please Login or

Read More »

Part 2: “There Have Been Challenges Up and Down the Supply Chain”: The View from the Field and Responses from Stakeholders

Beth Peery is the 340B Coordinator at Memorial Health Systems in Seward, Nebraska, a town of 6,000 in the southeastern part of the state.

A Special Report From 340B Report:
A two-part series on the growing frustrations safety net providers face in restoring access to 340B pricing in the contract pharmacy setting. Part 1 provides important background on the challenges that

Read More »

“I Don’t Want to Go Through This Nightmare”: Frustrations Grow Over Significant Delays in Restoration of 340B Pricing for Contract Pharmacy Purchases

A Special Report From 340B Report:
A two-part series on the growing frustrations safety net providers face in restoring access to 340B pricing in the contract pharmacy setting. Part 1 provides important background on the challenges that covered entities

Read More »

Biden Administration Kills Trump-era Rules Casting Doubt on HHS Guidance and Enforcement Actions

The Biden administration repealed Trump-era rules that it said hindered HHS from issuing guidance and bringing enforcement actions.

The Biden administration yesterday repealed Trump administration final rules that it said hindered the U.S. Health and Human Services Department’s (HHS) ability “to issue guidance, bring enforcement actions, and take other appropriate actions that advance the department’s mission.”

Read More »

Hospital Groups Cheer, Private Cancer Docs Deplore CMS’s Decision to End Deep Cut in 340B Hospitals’ Drug Payments

340B hospitals are happy that CMS has decided to end a deep cut in the hospitals' Medicare drug reimbursement. Private oncology practices call the decision "“an outrageous dereliction of duty."

Groups that represent 340B hospitals praised the Biden administration’s decision Friday to end a deep cut in the hospitals’ Medicare Part B drug reimbursement in place since 2018. They urged the government to swiftly make 340B hospitals whole

Read More »

HRSA’s 340B Program Website Gets a New Look

HRSA refreshed its 340B drug pricing program website last week, the first major change in the site's appearance in about four years.

The U.S. Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA), the unit within the Health and Human Services Department (HHS) that runs 340B, refreshed the OPA site last week.

Please Login or Become

Read More »

Breaking News

In Big Win For 340B Hospitals, CMS Will Reverse Massive Drug Reimbursement Cut for 2023 and Seeks Input on Potential Remedies for Prior Years

CMS announced late today that they are reversing significant Medicare cuts to 340B hospitals.

The U.S. Centers for Medicare and Medicaid Services “fully anticipate[s]” applying a Medicare Part B reimbursement rate next year of average sales price ASP plus 6% to drugs and biologicals purchased through the 340B program, CMS announced late this afternoon.

Read More »

HHS Warns Pharmacies Not to Turn Away Women Requesting Abortion Medication

HHS issued guidance to retail pharmacies about their legal duty to fill prescriptions for drugs that can end or prevent pregnancy.

The U.S. Department of Health and Human Services issued guidance to retail pharmacies yesterday about their “unique role … in ensuring access to comprehensive reproductive health care services”—including filling prescriptions for drugs that can end or prevent pregnancy.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report